Zeffix, Lösung zum Einnehmen

7680548690104 CH-54869 Lösung
Zeffix, Lösung zum Einnehmen
Zeffix, Lösung zum Einnehmen
Zeffix, Lösung zum Einnehmen
1 / 3
google

Article details

Package size
240
Selling units
240
Measure
ml
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
200.0 MG Substance HBESI
(N/A)
20.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
180.0 UG Substance HBESI
(N/A)
1.5 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
44.8 UG Substance HBESI
(N/A)
0.02 UG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
18.6 UG Substance HBESI
(N/A)
0.01 UG Substance HBESI
(N/A)
2.94 MG Substance HBESI

Reimbursement information

Public price
CHF 46.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2000

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
54869
Drug name
Zeffix, Lösung zum Einnehmen
Galenic form
LSOR
ATC Code
J05AF05
Authorization status
Z
Dispensing category
A
First authorization
24/03/1999
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Chronische Hepatitis B

Package details

Description (FR)
ZEFFIX sol buv s alcool fl 240 ml
Description (DE)
ZEFFIX Trink Lös o Alkohol Fl 240 ml
Market launch
24/03/1999
Narcotic (BTM)
No

Available generics (2)

Lamivudin-Mepha 150/300, Filmtabletten
GTIN: 7680605160038
CHF 169.80
View
Lamivudin-Mepha 150/300, Filmtabletten
GTIN: 7680605160045
CHF 169.80
View